Surgery Partners (SGRY) Scheduled to Post Quarterly Earnings on Tuesday

Surgery Partners (NASDAQ:SGRY) is scheduled to release its earnings data before the market opens on Tuesday, May 7th. Analysts expect Surgery Partners to post earnings of $0.07 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Monday, February 26th. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.07. Surgery Partners had a negative net margin of 0.43% and a positive return on equity of 3.65%. The business had revenue of $735.40 million during the quarter, compared to analysts’ expectations of $741.93 million. During the same period last year, the business earned $0.22 earnings per share. The firm’s revenue was up 4.0% on a year-over-year basis. On average, analysts expect Surgery Partners to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Surgery Partners Price Performance

NASDAQ:SGRY opened at $24.53 on Monday. Surgery Partners has a 1-year low of $22.05 and a 1-year high of $45.79. The company has a current ratio of 1.71, a quick ratio of 1.57 and a debt-to-equity ratio of 0.89. The firm has a fifty day simple moving average of $27.63 and a 200 day simple moving average of $29.79. The stock has a market capitalization of $3.12 billion, a PE ratio of -245.30, a P/E/G ratio of 2.24 and a beta of 2.75.

Analysts Set New Price Targets

Several research firms recently weighed in on SGRY. Royal Bank of Canada reissued an “outperform” rating and issued a $49.00 target price on shares of Surgery Partners in a research note on Thursday, February 29th. Benchmark reaffirmed a “buy” rating and set a $50.00 price objective on shares of Surgery Partners in a research report on Wednesday, May 1st. StockNews.com raised shares of Surgery Partners from a “sell” rating to a “hold” rating in a research report on Thursday, March 21st. Citigroup reduced their price objective on shares of Surgery Partners from $43.00 to $42.00 and set a “buy” rating for the company in a research report on Tuesday, February 27th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a research report on Wednesday, April 10th. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $43.63.

Insider Activity

In other news, CFO David T. Doherty sold 1,020 shares of the business’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $34.93, for a total value of $35,628.60. Following the completion of the sale, the chief financial officer now owns 74,209 shares of the company’s stock, valued at $2,592,120.37. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, CEO Jason Eric Evans sold 5,780 shares of the stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $35.08, for a total value of $202,762.40. Following the completion of the transaction, the chief executive officer now owns 419,118 shares of the company’s stock, valued at approximately $14,702,659.44. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO David T. Doherty sold 1,020 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $34.93, for a total transaction of $35,628.60. Following the completion of the sale, the chief financial officer now owns 74,209 shares in the company, valued at approximately $2,592,120.37. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 14,831 shares of company stock valued at $482,609. 2.60% of the stock is owned by company insiders.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.